NVO

P/E 11.41.00% yield

Novo Nordisk ADR

Sector: Health Care

As of Sep 1, 2026

100

$45.12

-29.68% below 52w high of $64.16

BEAR MARKET

Valuation Measures

Is the discount real? Stock vs sector vs market on P/E, P/B and P/S

P/E11.4 vs 22.7 marketCheaper

P/B6.00 vs -- market--

P/S4.03 vs -- market--

Relative Performance (12M)

NVO vs XLV vs SPY — % change from the window start

Laggard score 58.5

How lagging is this stock? Note: the stock's rank is set by P/E, not this score.

Drawdown Severity

Distance below the 52-week high

-29.7%

below 52-week high

BEAR MARKET

>10%

Correction

>20%

Bear

>30%

MAJOR bear

Returns Profile

Trailing 1, 3, 6 and 12-month price returns

EPS & Growth

Trailing EPS vs consensus estimates

$3.96

Qtr growth YoY -20.61%Profit margin 35.4%

Large-cap benchmark: ~15% EPS growth

Estimates: current & next fiscal year consensus (5-year outlook not provided).

Analyst Target

Wall Street consensus vs current price

No analyst target available

Risk Ladder

The methodology's 1–10 volatility scale — where every asset class sits (video @62:44)

Cash/T-bills

Index funds

Diversified stock funds

Sector ETFs & stocks

Sector ETFs & individual stocks sit at level 10 — maximum volatility

Rank History

Rank over time · 41 snapshots

Educational information, not an investment recommendation. Data may be delayed or incomplete. Do your own research before investing.